Skip to main content
Unknown status

Palliative Treatment With Liposomal Doxorubicin Plus Cisplatin for Patients With Malignant Pleural Mesothelioma

By April 24, 2017No Comments

Condition

Malignant Pleural Mesothelioma

Estimated Enrollment: 31

Age Group: 18 Years to 80 Years   (Adult, Senior)

Gender: All

Study Type: Interventional

Study Design Allocation: Allocation: Non-Randomized|Intervention Model: Single Group Assignment|Masking: Open Label|Primary Purpose: Treatment

Study ID Numbers: CB/304/06|007/024/OMI

Study First Received: April 20, 2009

Last Updated: April 21, 2009

Estimated Primary Completion Date: April 2009

 

Primary Outcome Measures:

Progression free survival|Over-all survival

Sponsors and Collaborators:

National Institute of Cancerología

Website Link: https://ClinicalTrials.gov/show/NCT00886028

Leave a Reply